IXHL Incannex Corp Net earnings per share (EPS TTM)

Official company branding of Incannex (IXHL)

Incannex Healthcare develops cannabinoid-based drugs to combat anxiety and apnea. The company's net income per share over 12 months illustrates this consumer inertia, while the -1.67 metric reflects current dynamics. The business relies on an ecosystem of clinical trials in Australia and the US under FDA supervision. The operating model is based on outsourcing production and marketing to third-party contractors.

IXHL (Incannex Healthcare) Net earnings per share for the last four quarters history from 04/28/2023 to 11/13/2026

IXHL (Incannex Healthcare Ltd): analytical breakdowns and indicator data

- current quotes and average value forecast:
Price Chart Incannex Healthcare|IXHL - Average Forecast Price
- market capitalization data:
Market Capitalization Incannex Healthcare Limited|IXHL - Business Value
- business book valuation details:
Book Value per Share Incannex Healthcare|IXHL - Book Valuation of Business|Market Value to Book Value Ratio incannex.com.au|IXHL - Total Business Assets
- debt burden and liquidity indicators:
Total Debt to Capital Incannex Healthcare|IXHL - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Incannex|IXHL - Company Aggregate Debts|Debt to Book Capitalization Ratio Incannex Healthcare Limited|IXHL - Company Long-Term Indebtedness|Company Short-Term Debt Incannex Healthcare|Quick Ratio incannex.com.au
- net income and valuation multiples indicators:
IXHL - Company Net Income|Future Profit Incannex Healthcare|IXHL - Price to Earnings Multiple|Projected Price to Earnings Incannex Healthcare Limited|IXHL - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Incannex Healthcare Limited|IXHL - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Incannex Healthcare|IXHL - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth incannex.com.au|IXHL - Earnings growth in current year|Net earnings per share growth forecast for next year Incannex Healthcare
Analysis of all company metrics:IXHL - Incannex Healthcare
Manufactured products of Incannex Healthcare Ltd

The development of therapies for sleep apnea and anxiety disorders drives the financial dynamics of Incannex Healthcare (IXHL). By analyzing the 12-month rolling earnings per share (EPS), an investor sees the result of dividing the total annual net income by the total number of outstanding shares. This metric strips profit of the influence of capital volume, revealing the actual efficiency of each share. The current trend reflects the company's ability to monetize clinical successes, allowing for an objective assessment of business resilience amid FDA regulatory expectations.

Direct competitors

PM - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months bat.com|MO: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BUD|DEO (Diageo Group) - Net earnings per share (EPS TTM)|Corona US (STZ) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Brown-Forman (BF-A)|Molson Coors Beverage Company - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) SAM (Boston Beer Company)|RLX - Net earnings per share for the last 12 months|Turning Point Brands Corp - Net earnings per share (EPS TTM)|UVV - Net earnings per share (EPS TTM)|Tilray Brands, Inc. (TLRY) - Earnings per share for the last twelve months|Earnings per share for the last 12 months SNDL|Earnings per share for the last twelve months MGP Ingredients|Earnings per share for the last 12 months EPSM (Epsium Enterprise Limited)|Net earnings per share (EPS TTM) OGI|MAPS - Net earnings per one share for the last twelve months|Ispire Technology Inc. - Net earnings per share for the last 12 months|WVVI: Earnings per share for the last 12 months|YHC: Net earnings per share for the last 12 months|Earnings per share for the trailing year XXII (22nd Century Group)|KAVL: Net earnings per share (EPS TTM)|Innovation Beverage Corp - Earnings per share for the trailing year|CASK (Heritage Distilling Company) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Papa Medical Corp PAPA|Net earnings per share (EPS TTM) EAST|Net earnings per share (EPS TTM) Leafly Holdings (LFLY)|Earnings per share for the last twelve months LQR House Corp LQR|Duckhorn Portfolio Inc - Earnings per share for the last twelve months|VINE: Net earnings per share for the last 12 months|Vintage Wine Estates Inc. - Earnings per share for the last four quarters|VAPE: Net earnings per share (EPS TTM)